IMPACT OF FIX ACTIVITY ASSAY RESULTS DETERMINED WITH ONE-STAGE CLOTTING AND CHROMOGENIC ASSAYS ON THE CLASSIFICATION OF HAEMOPHILIA B

被引:0
|
作者
Pavic, J. [1 ,2 ]
Milos, M. [3 ]
Herak, Coen D. [3 ]
Juros, Fressl G. [4 ]
Boban, A. [5 ]
Bilic, E. [6 ]
Salek, Zupancic S. [7 ]
Zadro, R. [8 ]
机构
[1] Gen Cty Hosp Livno, Dept Med Biochem, Livno, Bosnia & Herceg
[2] Gen Cty Hosp Livno, Haematol Lab, Livno, Bosnia & Herceg
[3] Univ Hosp Ctr Zagreb, Dept Lab Diagnost, Zagreb, Croatia
[4] Srebrnjak Childrens Hosp, Dept Clin Lab Diagnost, Zagreb, Croatia
[5] Univ Hosp Ctr Zagreb, Dept Internal Med, Zagreb, Croatia
[6] Univ Hosp Ctr Zagreb, Dept Pediat, Zagreb, Croatia
[7] Univ Zagreb, Sch Med, Zagreb, Croatia
[8] St Catherine Specialty Hosp, Med Biochem Lab, Zagreb, Croatia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PO-09
引用
收藏
页码:20 / 20
页数:1
相关论文
共 50 条
  • [1] Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B
    Kihlberg, Kristina
    Strandberg, Karin
    Ljung, Rolf
    Berntorp, Erik
    Astermark, Jan
    HAEMOPHILIA, 2016, 22 : 70 - 70
  • [2] Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B
    Kihlberg, K.
    Strandberg, K.
    Rosen, S.
    Ljung, R.
    Astermark, J.
    HAEMOPHILIA, 2017, 23 (04) : 620 - 627
  • [3] Clinical utility and impact of the use of the chromogenic vs one-stage factor activity assays in haemophilia A and B
    Marlar, Richard A.
    Strandberg, Karin
    Shima, Midori
    Adcock, Dorothy M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (01) : 3 - 14
  • [4] Advantages, disadvantages and optimization of one-stage and chromogenic factor activity assays in haemophilia A and B
    Adcock, D. M.
    Strandberg, K.
    Shima, M.
    Marlar, R. A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (06) : 621 - 629
  • [5] One-stage vs. chromogenic assays in haemophilia A
    Potgieter, Joachim J.
    Damgaard, Michael
    Hillarp, Andreas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 : 38 - 44
  • [6] Discrepant one-stage clotting versus chromogenic FVIII assays in haemophilia patients on Refacto AF
    Anwar, M.
    Uprichard, J.
    Austin, S. K.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 : 13 - 13
  • [7] Determination of clotting factor VIII activity in mammals using one-stage clotting and chromogenic assays
    Lutze, G
    Lutze, G
    Kutschmann, K
    Schröpel, M
    BERLINER UND MUNCHENER TIERARZTLICHE WOCHENSCHRIFT, 2002, 115 (7-8): : 297 - 302
  • [8] The activity of GlycoPEGylated recombinant FIX (N9-GP) can be measured in two-stage chromogenic and one-stage clotting assays
    Holm, P. K.
    Sorensen, M. H.
    Hermit, B. M.
    Ezban, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 828 - 828
  • [9] Impact of variation in reagent combinations for one-stage clotting assay on assay discrepancy in nonsevere haemophilia A
    Suzuki, Atsuo
    Suzuki, Nobuaki
    Kanematsu, Takeshi
    Okamoto, Shuichi
    Tamura, Shogo
    Kikuchi, Ryosuke
    Katsumi, Akira
    Kiyoi, Hitoshi
    Kojima, Tetsuhito
    Matsushita, Tadashi
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2021, 43 (01) : 131 - 138
  • [10] Evaluation of Chromogenic Factor VIII Assay Compared with One-Stage Clotting Assay
    Akkaya, Emre
    Hatiboglu, Songul
    Koc, Basak
    Genc, Sema
    Unuvar, Aysegul
    Karaman, Serap
    Omer, Beyhan
    Karakas, Zeynep
    Zulfikar, Bulent
    CLINICAL LABORATORY, 2020, 66 (10) : 1937 - 1943